# Stuart Peterson

> Stuart Peterson is the Founder and Managing General Partner of ARTIS Ventures, a San Francisco-based venture capital firm he launched in 2001 that coined and trademarked the term 'TechBio.' A 2017 Forbes Midas List honoree, Peterson led early-stage investments in YouTube (acquired by Google) and StemCentrx (acquired by AbbVie for $10.2 billion - the largest-ever venture-backed life sciences acquisition), and has since focused ARTIS at the convergence of computer science and life science, closing a $200 million TechBio II Fund in December 2023 to back next-generation health and medicine companies deploying AI, machine learning, and deep learning to transform human health.

- **Role:** Managing General Partner and Founder at ARTIS Ventures
- **Organizations:** ARTIS Ventures, SFMOMA (Board of Trustees), Human Needs Project, Tipping Point Community, Conceivable Life Sciences (Board), TAE Life Sciences (Board), Rad AI (Board), Affect Therapeutics (Board), OPYN Health (Board), Cohesity (Board), Versa Networks (Board), Unnatural Products (Board)
- **Nationality:** American
- **Education:** Bachelor of Arts, Economics, University of California, Los Angeles (UCLA), MBA, Analytic Finance, University of Chicago Booth School of Business
- **Known for:** 2017 Forbes Midas List honoree, TechCrunch VC of the Year Finalist, New York Times and CB Insights Top 100 Venture Capitalist

## Career timeline

- **2001** — Founded ARTIS Ventures in San Francisco, CA
- **2005** — Led early-stage investment in YouTube
- **2006** — YouTube acquired by Google; ARTIS exit
- **2011** — Led first institutional round for StemCentrx - $18M in $25M total round
- **2016** — StemCentrx acquired by AbbVie for $10.2 billion - largest-ever venture-backed life sciences acquisition
- **2017** — Named to Forbes Midas List; TechCrunch VC of the Year Finalist; NY Times/CB Insights Top 100 VC
- **2007-present** — Board of Trustees, San Francisco Museum of Modern Art (SFMOMA)
- **2021** — ARTIS Ventures coins and trademarks the term 'TechBio'
- **2023** — Co-founded ONTO Health (Onto Fertility)
- **2023-12** — Closed TechBio II Fund at $200M dedicated to AI/ML-driven health innovation
- **2024** — Led Rad AI Series B ($50M)
- **2025** — Led Conceivable Life Sciences Series A ($50M) and Affect Therapeutics Series B ($26M)
- **2026** — Led Onto Health Series A ($20M)

## Achievements

- 2017 Forbes Midas List honoree
- TechCrunch VC of the Year Finalist
- New York Times and CB Insights Top 100 Venture Capitalist
- Valuer Top 100 Venture Capitalist in the US
- Led early-stage investment in YouTube before Google acquisition
- Led first institutional round in StemCentrx ($18M), which sold to AbbVie for $10.2B - largest-ever venture-backed life sciences acquisition
- Founded ARTIS Ventures in 2001 - over two decades of operations
- Coined and trademarked the term 'TechBio'
- Backed IPOs including Palantir, Nimble Storage, and Aruba Networks
- Closed $200M TechBio II Fund in December 2023
- Board of Trustees at SFMOMA since 2007
- Co-founded FIG (Food is Good) and ONTO Health

## Latest updates

- **2026-04** — Led Onto Health Series A financing ($20M)
- **2025-09** — Led Conceivable Life Sciences Series A ($50M) and Affect Therapeutics Series B ($26M)
- **2025-02** — Led Network Bio Seed round ($17M)
- **2024-05** — Led Rad AI Series B ($50M)
- **2023-12** — ARTIS Ventures closed TechBio II Fund at $200M dedicated to AI-driven health innovation

## Links

- Website: https://av.co
- LinkedIn: http://www.linkedin.com/in/petersonstuart
- Twitter/X: https://twitter.com/artisventures
- Facebook: https://facebook.com/ARTISventures

---

Profile page: https://yespress.io/stuart-peterson
Published by YesPress — https://yespress.io
Last updated: 2026-05-17